Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Serna-Blasco

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|January 10, 2019
Targeting KRAS Mutant CMS3 Subtype by Metabolic InhibitorsOscar Aguilera, Roberto Serna-Blasco
Chest|February 11, 2026
ResponseRoberto Serna-Blasco, Atocha Romero, Mariano Provencio
Current Treatment Options in Oncology|August 23, 2021
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung CancerAtocha Romero, Roberto Serna-Blasco, Virginia Calvo, et al.
Seminars in Cancer Biology|February 13, 2018
Targeting the RAS-dependent chemoresistance: The Warburg connectionRoberto Serna-Blasco, Marta Sanz-Álvarez, Óscar Aguilera, et al.
Molecular Oncology|September 28, 2022
Cancer as an infective disease: the role of EVs in tumorigenesisLucia Robado de Lope, Estela Sánchez-Herrero, Roberto Serna-Blasco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2025
Adoptive cell therapies in thoracic malignancies: a comprehensive reviewYago Garitaonaindia, Marta Martínez-Cutillas, Maria Uribarren, et al.
Frontiers in Oncology|August 8, 2022
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA AnalysisEstela Sánchez-Herrero, Roberto Serna-Blasco, Lucia Robado de Lope, et al.
Biology|October 23, 2021
R-Score: A New Parameter to Assess the Quality of Variants' Calls Assessed by NGS Using Liquid BiopsiesRoberto Serna-Blasco, Estela Sánchez-Herrero, María Berrocal Renedo, et al.
World Journal of Surgery|May 26, 2018
Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer PatientsBlanca Torrejón, Ion Cristóbal, Cristina Caramés, et al.
Theranostics|March 5, 2021
Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic <i>KRAS</i> mutant colon cancerAiora Cenigaonandia-Campillo, Roberto Serna-Blasco, Laura Gómez-Ocabo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|January 10, 2019
Targeting KRAS Mutant CMS3 Subtype by Metabolic InhibitorsOscar Aguilera, Roberto Serna-Blasco
Chest|February 11, 2026
ResponseRoberto Serna-Blasco, Atocha Romero, Mariano Provencio
Current Treatment Options in Oncology|August 23, 2021
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung CancerAtocha Romero, Roberto Serna-Blasco, Virginia Calvo, et al.
Seminars in Cancer Biology|February 13, 2018
Targeting the RAS-dependent chemoresistance: The Warburg connectionRoberto Serna-Blasco, Marta Sanz-Álvarez, Óscar Aguilera, et al.
Molecular Oncology|September 28, 2022
Cancer as an infective disease: the role of EVs in tumorigenesisLucia Robado de Lope, Estela Sánchez-Herrero, Roberto Serna-Blasco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2025
Adoptive cell therapies in thoracic malignancies: a comprehensive reviewYago Garitaonaindia, Marta Martínez-Cutillas, Maria Uribarren, et al.
Frontiers in Oncology|August 8, 2022
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA AnalysisEstela Sánchez-Herrero, Roberto Serna-Blasco, Lucia Robado de Lope, et al.
Biology|October 23, 2021
R-Score: A New Parameter to Assess the Quality of Variants' Calls Assessed by NGS Using Liquid BiopsiesRoberto Serna-Blasco, Estela Sánchez-Herrero, María Berrocal Renedo, et al.
World Journal of Surgery|May 26, 2018
Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer PatientsBlanca Torrejón, Ion Cristóbal, Cristina Caramés, et al.
Theranostics|March 5, 2021
Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic <i>KRAS</i> mutant colon cancerAiora Cenigaonandia-Campillo, Roberto Serna-Blasco, Laura Gómez-Ocabo, et al.
Pageof 3